PIGR and colorectal carcinoma: For example, PIGR can not only promote the malignant progression of hepatocellular carcinoma and pancreatic ductal adenocarcinoma [14–17], but also inhibit cell proliferation and motility in lung cancer, endometrial adenocarcinoma, and CRC [18–20].